Previous Close | 192.86 |
Open | 193.47 |
Bid | 192.15 x 1800 |
Ask | 196.00 x 900 |
Day's Range | 192.83 - 194.70 |
52 Week Range | 135.85 - 199.95 |
Volume | |
Avg. Volume | 5,231,411 |
Market Cap | 341.61B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 64.47 |
EPS (TTM) | 3.00 |
Earnings Date | Oct 25, 2024 - Oct 29, 2024 |
Forward Dividend & Yield | 6.20 (3.21%) |
Ex-Dividend Date | Oct 15, 2024 |
1y Target Est | 197.33 |
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share.
The fact that multiple AbbVie Inc. ( NYSE:ABBV ) insiders offloaded a considerable amount of shares over the past year...
Investors who own ABBV stock may stay invested as the company has faced its biggest challenge, Humira's patent cliff, quite well and looks set to return to robust growth next year.